Clinical Trial Update: ERG/EOG Study in AMD Patients Treated With Ranibizumab

View source ↗

Summary

This update reports the completion of an ERG/EOG study evaluating retinal function in age-related macular degeneration patients treated with ranibizumab.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Ranibizumab (ranibizumab)

Snippet

Sponsor: Retina Center, Minnesota | Conditions: Age-Related Macular Degeneration | Status: COMPLETED